Health Secretary Seeks Peptide Ban Reversal

HHS Secretary Robert F. Kennedy Jr. has criticized the FDA’s 2023 decision that placed 19 peptides on an 'unsafe' list and is preparing to roll back that policy even though few new clinical studies justify such a change. Former FDA officials tell reporters the secretary mischaracterized their findings and that the original move was supported by documented safety concerns. — If a politically appointed health secretary reverses evidence‑based safety rulings, it sets a precedent for undermining regulatory science and potentially increases patient risk from untested compounded therapies.